Scientific Sessions 2025  /  EHJ and Circulation: Advances in 2025  /  The Year in Genomic Medicine
Logo

American Heart Association

  48
  0

Final ID:

The Year in Genomic Medicine

  • Shah, Svati  ( DUKE UNIV MEDICAL CENTER , Hillsborough , North Carolina , United States )
  • Schunkert, Heribert  ( German Heart Center , Munich , Germany )
    • Author Disclosures:
    Svati Shah: DO NOT have relevant financial relationships | Heribert Schunkert: DO have relevant financial relationships ; Consultant:AMGEN:Active (exists now) ; Speaker:Amarin:Past (completed) ; Speaker:Bristol-Myers Squibb:Active (exists now) ; Speaker:Synlab:Active (exists now) ; Speaker:Sanofi-Aventis:Active (exists now) ; Speaker:Servier:Active (exists now) ; Speaker:Novartis:Active (exists now) ; Speaker:Bayer Vital:Active (exists now) ; Speaker:AstraZeneca:Active (exists now) ; Consultant:Daiichi-Sankyo:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:AstraZeneca:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

EHJ and Circulation: Advances in 2025

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
The Year in Vascular Medicine

Beckman Joshua, Landmesser Ulf

The Year in Cardiovascular AI

Oikonomou Evangelos, Mills Nicholas

More abstracts from these authors:
Metabolomic Profiling of SLGT2 Inhibitors in Heart Failure

Shah Svati

Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction

Shah Svati

You have to be authorized to contact abstract author. Please, Login
Not Available